Nanomedicine in the face of Parkinson's disease: from drug delivery systems to nanozymes
The complexity and overall burden of Parkinson's disease (PD) require new
pharmacological approaches to counteract the symptomatology while reducing the …
pharmacological approaches to counteract the symptomatology while reducing the …
Catalytic nanomedicine: a brief review of bionanocatalysts
TM López-Goerne, FJ Padilla-Godínez… - …, 2022 - Taylor & Francis
Catalytic nanomedicine is a research area and source of disruptive technology that studies
the application of bionanocatalysts (organically functionalized mesoporous nanostructured …
the application of bionanocatalysts (organically functionalized mesoporous nanostructured …
Catalytic Nanomedicine: Coated bionanocatalysts for Catalytic Antineoplastic activity
T López-Goerne, E Ortiz-Islas, F Rodríguez-Reinoso… - Adsorption, 2024 - Springer
Glioma tumors are the most common form of central nervous system tumors, and there is a
pressing need for innovative methods that can precisely target cancer cells while leaving …
pressing need for innovative methods that can precisely target cancer cells while leaving …
[PDF][PDF] Nanomedicine in the Face of Parkinson's Disease: From Drug Delivery Systems to Nanozymes. Cells 2022, 11, 3445
FJ Padilla-Godínez, LI Ruiz-Ortega, M Guerra-Crespo - 2022 - researchgate.net
The complexity and overall burden of Parkinson's disease (PD) require new
pharmacological approaches to counteract the symptomatology while reducing the …
pharmacological approaches to counteract the symptomatology while reducing the …
[PDF][PDF] Maestría y Doctorado en Ciencias Bioquímicas
M en Ciencias - 2023 - ru.dgb.unam.mx
La infección con el Virus de Papiloma Humano de alto riesgo (VPH-AR) es la principal
causa para el desarrollo de cáncer cervical (CC), en el que la continua expresión de las …
causa para el desarrollo de cáncer cervical (CC), en el que la continua expresión de las …